Cargando…

Pathological Diagnosis, Work-Up and Reporting of Breast Cancer 1st Central-Eastern European Professional Consensus Statement on Breast Cancer

This text is based on the recommendations accepted by the 4th Hungarian Consensus Conference on Breast Cancer, modified on the basis of the international consultation and conference within the frames of the Central-Eastern European Academy of Oncology. The recommendations cover non-operative, intrao...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cserni, Gábor, Francz, Monika, Járay, Balázs, Kálmán, Endre, Kovács, Ilona, Krenács, Tibor, Tóth, Erika, Udvarhelyi, Nóra, Vass, László, Vörös, András, Krivokuca, Ana, Kajo, Karol, Kajová Macháleková, Katarína, Kulka, Janina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284216/ https://www.ncbi.nlm.nih.gov/pubmed/35845921 http://dx.doi.org/10.3389/pore.2022.1610373

Ejemplares similares

Editorial: Guidelines From the Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kulka, Janina, et al.
Publicado: (2022)

Syntaxin-1 and Insulinoma-Associated Protein 1 Expression in Breast Neoplasms with Neuroendocrine Features
por: Turkevi-Nagy, Sándor, et al.
Publicado: (2021)

Radiotherapy of Breast Cancer—Professional Guideline 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Polgár, Csaba, et al.
Publicado: (2022)

Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
por: Olah, Orsolya, et al.
Publicado: (2023)

Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Forrai, Gábor, et al.
Publicado: (2022)

Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Rubovszky, Gábor, et al.
Publicado: (2022)

Modern Breast Cancer Surgery 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Mátrai, Zoltán, et al.
Publicado: (2022)

Corrigendum: Systemic treatment of breast cancer. 1st Central-Eastern European professional Consensus Statement on breast cancer
por: Rubovszky, Gábor, et al.
Publicado: (2023)

Breast Cancer Survivorship Programme: Follow-Up, Rehabilitation, Psychosocial Oncology Care. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Kahán, Zsuzsanna, et al.
Publicado: (2022)

Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
por: Forika, Gertrud, et al.
Publicado: (2021)

Correlations Between the Expression of Stromal Cell Activation Related Biomarkers, L-NGFR, Phospho-ERK1-2 and CXCL12, and Primary Myelofibrosis Progression
por: Szekely, Tamas, et al.
Publicado: (2022)

A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with “bone-only” metastatic breast cancer
por: Tornyi, Ilona, et al.
Publicado: (2023)

Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
por: Deme, Daniel, et al.
Publicado: (2022)

Corrigendum: Overall Survival Prediction of Advanced Cancer Patients by Selection of the Most Significant Baseline Serum Biomarker Combination
por: Deme, Daniel, et al.
Publicado: (2022)

Correlation analysis of circulating tumor cells and Claudin-4 in breast cancer
por: Chai, Jie, et al.
Publicado: (2023)

Unusual Occurrence of Rare Lipid-Rich Carcinoma and Conventional Invasive Ductal Carcinoma in the One Breast: Case Report
por: Machalekova, Katarina, et al.
Publicado: (2012)

Comprehensive Analysis of Metabolic Genes in Breast Cancer Based on Multi-Omics Data
por: Hua, Yu, et al.
Publicado: (2021)

NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer
por: Yang, Yuting, et al.
Publicado: (2023)

Anterior Gradient 2 is a Significant Prognostic Biomarker in Bone Metastasis of Breast Cancer
por: Li, Jin-Jin, et al.
Publicado: (2022)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Lin, Yuxiang, et al.
Publicado: (2022)

Immunohistochemical Expressions of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer
por: Park, Min Hui, et al.
Publicado: (2021)

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy
por: Tan, Shirong, et al.
Publicado: (2021)

Improved Accuracy of Lymph Node Staging and Long-Term Survival Benefit in Colorectal Cancer With Ex Vivo Arterial Methylene Blue Infiltration
por: Suszták, Nóra, et al.
Publicado: (2022)

Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma
por: Zhang, Letian, et al.
Publicado: (2023)

Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy
por: Pfaendler, Krista S, et al.
Publicado: (2022)

Intracystic endometrioid borderline tumor
por: El Hajj, Houssein, et al.
Publicado: (2023)

Stat3 Tyrosine 705 and Serine 727 Phosphorylation Associate With Clinicopathological Characteristics and Distinct Tumor Cell Phenotypes in Triple-Negative Breast Cancer
por: Stenckova, Michaela, et al.
Publicado: (2022)

Expression of Concern: Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma
Publicado: (2023)

3D bioprinting and the revolution in experimental cancer model systems—A review of developing new models and experiences with in vitro 3D bioprinted breast cancer tissue-mimetic structures
por: Sztankovics, Dániel, et al.
Publicado: (2023)

Apocrine Encapsulated Papillary Carcinoma of the Breast: The First Reported Case with an Infiltrative Component
por: Kővári, Bence, et al.
Publicado: (2018)

The characteristics of head and neck squamous cell cancer in young adults: A retrospective single-center study
por: Révész, Mónika, et al.
Publicado: (2023)

Novel Diagnostic Value of Driver Gene Transcription Signatures to Characterise Clear Cell Renal Cell Carcinoma, ccRCC
por: Ujfaludi, Zsuzsanna, et al.
Publicado: (2022)

The Prevalence of High-Risk Human Papillomavirus in Hungary—A Geographically Representative, Cross-Sectional Study
por: Fogarasi, András István, et al.
Publicado: (2022)

Effective venetoclax-based treatment in relapsed/refractory multiple myeloma patients with translocation t(6;14)
por: Ceglédi, Andrea, et al.
Publicado: (2023)

Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric Leukemia
por: Egyed, Bálint, et al.
Publicado: (2022)

Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma
por: Wiedemann, Ádám, et al.
Publicado: (2023)

Comparison of Cancer Survival Trends in Hungary in the Periods 2001–2005 and 2011–2015 According to a Population-Based Cancer Registry
por: Kenessey, István, et al.
Publicado: (2022)

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
por: Paszt, Attila, et al.
Publicado: (2022)

TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin
por: Almási, Szintia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tjvtpqf90om9qjl294hbb3rv5g